Ireland Health News API

{
    "totalArticles": 2137166,
    "articles": [
        {
            "title": "Common Virus Improves Melanoma Treatment Response, Reduces Side Effects",
            "description": "Patients who were positive for cytomegalovirus had more immune cells circulating in their blood before they started immunotherapy. This may be one reason why these patients responded better to certain immunotherapy treatments, researchers said.",
            "content": "A common virus carried by approximately half of adults worldwide may improve outcomes for melanoma patients receiving immunotherapy while also protecting against severe treatment-related side effects and limiting the spread, according to new research... [3708 chars]",
            "url": "https://www.managedhealthcareexecutive.com/view/common-virus-improves-melanoma-treatment-response-reduces-side-effects",
            "image": "https://cdn.sanity.io/images/0vv8moc6/mhe/8e4dfafce3bbd04c8bb2720eac6c67613bd0966e-3398x2266.jpg?fit=crop&auto=format",
            "publishedAt": "2025-05-09T13:18:26Z",
            "source": {
                "name": "Managed Healthcare Executive",
                "url": "https://www.managedhealthcareexecutive.com"
            }
        },
        {
            "title": "Vitamin Therapy May Protect Optic Nerve in Glaucoma Patients",
            "description": "Supplements of vitamins B6, B9, B12, and choline slowed or halted damage to the optic nerve in animal models of glaucoma.",
            "content": "A vitamin-based therapy aimed at improving retinal metabolism may offer a new neuroprotective strategy for patients with glaucoma, according to new research published in Cell Reports Medicine. The study, led by scientists at Sweden’s Karolinska Insti... [4732 chars]",
            "url": "https://www.insideprecisionmedicine.com/topics/patient-care/vitamin-therapy-may-protect-optic-nerve-in-glaucoma-patients/",
            "image": "https://www.insideprecisionmedicine.com/wp-content/uploads/2025/02/HumanEyeImage-990992114.jpg",
            "publishedAt": "2025-05-09T13:12:27Z",
            "source": {
                "name": "Inside Precision Medicine",
                "url": "https://www.insideprecisionmedicine.com"
            }
        },
        {
            "title": "Nitin Yerram, MD, on a urine-based diagnostic test for prostate cancer",
            "description": "The miR Sentinel Prostate Cancer Test is a standalone liquid biopsy urine test.",
            "content": "In an interview with Urology Times®, Nitin K. Yerram, MD, discusses the miR Sentinel Prostate Cancer Test, which is a standalone urine-based diagnostic biomarker for prostate cancer.\n“There's really a need in this area when it comes down to something... [592 chars]",
            "url": "https://www.urologytimes.com/view/nitin-yerram-md-on-a-urine-based-diagnostic-test-for-prostate-cancer",
            "image": "https://cdn.sanity.io/images/0vv8moc6/urologytimes/19ec93945c62f52257717240361ab5b82bac50b2-1200x673.png?fit=crop&auto=format",
            "publishedAt": "2025-05-09T13:04:11Z",
            "source": {
                "name": "Urology Times",
                "url": "https://www.urologytimes.com"
            }
        }
    ]
}